MicroRNAs involved in the TGF-β signaling pathway in atherosclerosis

Area of Science:

• Vascular Biology
• Molecular Medicine
• Inflammation Research

Background:

• Atherosclerosis (AS) is a complex, chronic inflammatory vascular disease with significant global health implications, particularly in the elderly.
• The precise mechanisms underlying AS pathogenesis remain incompletely understood.
• The transforming growth factor-β (TGF-β) signaling pathway is implicated in various cellular processes, including inflammation, immune response, proliferation, and apoptosis.

Purpose of the Study:

• To review and synthesize current knowledge on the role of microRNAs in atherosclerosis.
• To elucidate the involvement of the TGF-β signaling pathway in microRNA-mediated regulation of AS.
• To clarify the dual role of the TGF-β pathway in promoting or inhibiting atherosclerosis.

Main Methods:

• Literature review and synthesis of existing research.
• Analysis of studies investigating microRNA function in AS.
• Examination of the interplay between microRNAs and the TGF-β signaling pathway in vascular disease.

Main Results:

• MicroRNAs have emerged as key regulators of atherosclerosis.
• Evidence suggests microRNAs modulate AS pathogenesis specifically through the TGF-β signaling pathway.
• The precise influence of the TGF-β pathway on AS, as mediated by microRNAs, requires further clarification.

Conclusions:

• MicroRNAs play a critical role in the pathogenesis of atherosclerosis.
• The TGF-β signaling pathway is a significant mediator of microRNA effects in AS.
• Further research is warranted to fully understand the microRNA-TGF-β axis in atherosclerosis for potential therapeutic strategies.